• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Guardant Health, Inc. - Common Stock (NQ:GH)

41.42 +0.44 (+1.07%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,158,645
Open 40.75
Bid (Size) 40.65 (5)
Ask (Size) 44.10 (1)
Prev. Close 40.98
Today's Range 40.35 - 42.22
52wk Range 20.14 - 53.42
Shares Outstanding 101,298,669
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Guardant Health to Participate in the Canaccord Genuity 45th Annual Growth Conference
July 31, 2025
From Guardant Health, Inc.
Via Business Wire
Guardant Health Analysts Increase Their Forecasts After Stronger-Than-Expected Q2 Earnings
July 31, 2025
Via Benzinga

Performance

YTD
+30.4%
+30.4%
1 Month
-18.0%
-18.0%
3 Month
-6.0%
-6.0%
6 Month
-12.9%
-12.9%
1 Year
+30.5%
+30.5%

More News

Read More
Guardant Health (GH) Q2 Revenue Up 31%
July 31, 2025
Via The Motley Fool
Guardant Health (NASDAQ:GH) Beats Expectations in Strong Q2, Guides for Strong Full-Year Sales
July 30, 2025
Via StockStory
Earnings Scheduled For July 30, 2025
July 30, 2025
Via Benzinga
Guardant Health Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
July 30, 2025
From Guardant Health, Inc.
Via Business Wire
Guardant Health and James Van Der Beek Team Up to Raise Awareness About New Advances in Colorectal Cancer Screening for Adults 45+
July 30, 2025
From Guardant Health, Inc.
Via Business Wire
New RADIOHEAD Study Validates Use of Guardant Reveal Tissue-Free Monitoring for Earlier Detection of Immunotherapy Response in Advanced Cancer
July 29, 2025
From Guardant Health, Inc.
Via Business Wire
Guardant Health (GH) Q2 Earnings: What To Expect
July 28, 2025
Via StockStory
Cathie Wood's Ark Invest Loads Up On Absci, Offloads CRISPR Therapeutics
July 26, 2025
Via Benzinga
1 Healthcare Stock with Solid Fundamentals and 2 We Avoid
July 25, 2025
Via StockStory
Topics Stocks
1 Volatile Stock to Own for Decades and 2 We Brush Off
July 22, 2025
Via StockStory
Cathie Wood's Ark Invest Offloads Meta, Loads Up On Teradyne, Caris Life Sciences
July 19, 2025
Via Benzinga
Topics Artificial Intelligence
First Patient Enrolled in National Cancer Institute’s Vanguard Study Evaluating Guardant Health’s Shield Multi-Cancer Detection Test
July 15, 2025
From Guardant Health, Inc.
Via Business Wire
Guardant Health to Report Second Quarter 2025 Financial Results on July 30, 2025
July 14, 2025
From Guardant Health, Inc.
Via Business Wire
Guardant Health, Gilead Sciences, Inspire Medical Systems, Enovis, and AMN Healthcare Services Stocks Trade Down, What You Need To Know
July 11, 2025
Via StockStory
Topics ETFs Stocks World Trade
Could Personalized Medicine Be Your Portfolio's Next Big Winner? Find Out
June 25, 2025
Via Benzinga
Topics Artificial Intelligence
3 Cash-Burning Stocks Facing Headwinds
June 16, 2025
Via StockStory
3 of Wall Street’s Favorite Stocks Facing Headwinds
June 13, 2025
Via StockStory
2 Mooning Stocks Worth Your Attention and 1 to Be Wary Of
June 11, 2025
Via StockStory
Guardant Health Wins Fast Company’s 2025 World Changing Ideas Award for Shield Blood Test for Colorectal Cancer Screening
June 10, 2025
From Guardant Health, Inc.
Via Business Wire
New Study Published in ESMO Open Highlights Guardant Reveal's Performance in Detecting Minimal Residual Disease in Patients with Early-Stage Breast Cancer
June 09, 2025
From Guardant Health, Inc.
Via Business Wire
Cathie Wood's ARK Invest Buys More Amazon Stock: Retail Still On The Sidelines
June 03, 2025
Via Stocktwits
Topics ETFs World Trade
Why Guardant Health Stock Surged Nearly 9% Higher Today
June 03, 2025
Via The Motley Fool
Why Is Cancer Diagnostic Guardant Health Stock Trading Higher On Tuesday?
June 03, 2025
Via Benzinga

Frequently Asked Questions

Is Guardant Health, Inc. - Common Stock publicly traded?
Yes, Guardant Health, Inc. - Common Stock is publicly traded.
What exchange does Guardant Health, Inc. - Common Stock trade on?
Guardant Health, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Guardant Health, Inc. - Common Stock?
The ticker symbol for Guardant Health, Inc. - Common Stock is GH on the Nasdaq Stock Market
What is the current price of Guardant Health, Inc. - Common Stock?
The current price of Guardant Health, Inc. - Common Stock is 41.42
When was Guardant Health, Inc. - Common Stock last traded?
The last trade of Guardant Health, Inc. - Common Stock was at 08/01/25 04:00 PM ET
What is the market capitalization of Guardant Health, Inc. - Common Stock?
The market capitalization of Guardant Health, Inc. - Common Stock is 4.20B
How many shares of Guardant Health, Inc. - Common Stock are outstanding?
Guardant Health, Inc. - Common Stock has 4B shares outstanding.
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap